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Abstract
Background: Previous studies focusing on candidate genes and chromosomal regions identified several copy
number variations (CNVs) associated with increased risk of autism or autism spectrum disorders (ASD).
Case Presentation: We describe a 17-year-old girl with autism, severe mental retardation, epilepsy, and partial 9p
duplication syndrome features in whom GTG-banded chromosome analysis revealed a female karyotype with a
marker chromosome in 69% of analyzed metaphases. Array CGH analysis showed that the marker chromosome
originated from 9p24.3 to 9p13.1 with a gain of 38.9 Mb. This mosaic 9p duplication was detected only in the
proband and not in the parents, her four unaffected siblings, or 258 ethnic controls. Apart from the marker
chromosome, no other copy number variations (CNVs) were detected in the patient or her family. Detailed analysis
of the duplicated region revealed: i) an area extending from 9p22.3 to 9p22.2 that was previously identified as a
critical region for the 9p duplication syndrome; ii) a region extending from 9p22.1 to 9p13.1 that was previously
reported to be duplicated in a normal individual; and iii) a potential ASD locus extending from 9p24.3 to 9p23. The
ASD candidate locus contained 34 genes that may contribute to the autistic features in this patient.
Conclusion: We identified a potential ASD locus (9p24.3 to 9p23) that may encompass gene(s) contributing to
autism or ASD.
Background
Autism spectrum disorders (ASD), including autism, are
neuro-developmental disorders characterized by impair-
ment in social and communication skills together with
stereotyped and repetitive behavior and/or a restricted
range of interests. Current prevalence estimates in the
United States are 0.1-0.2% of live births for autism and
0.6% for ASD [1]. The exact prevalence of ASD in Saudi
Arabia is still undetermined, but one rough estimate
is 18 per 10,000, slightly higher than 13 per 10,000
reported in developed countries [2]. Reasons for a possi-
b l yh i g h e rp r e v a l e n c eo fA S Di nS a u d iA r a b i aa r en o t
clear but could relate in part to differences in diagnostic
practice, higher consanguinity rates, a founder effect, or
unidentified environmental risk factors.
Previous studies focusing on candidate genes and
chromosomal regions identified several copy number
variations (CNVs) associated with increased risk of ASD
[3-9]. Chromosomal regions implicated by these studies
include 1q, 1p, 5q, 7q, 15q, 16p, 17p, 20p, 3p, 10q, 15q,
20p, 22q and Xq with patients exhibiting variable
expressivity and associated phenotypes such as schizo-
phrenia, mental retardation, developmental delay, and
epilepsy [10]. The Autism Chromosome Rearrangement
Database (http://projects.tcag.ca/autism) currently lists
15 reports of autistic patients with chromosomal
anomalies involving 9p. Eleven of these cases involved
CNVs of 9p together with other chromosomes, while
four cases involved an isolated 9p deletion or inversion.
We describe a 17-year-old girl with autism, mental
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tion syndrome who has a mosaic marker chromosome
derived from 9p24.3 to 9p13.1.
Case Presentation
The proband (II-3, Figure 1A) was first examined at age
15 months because of seizures and developmental delay
and has been followed since then by MAS and MZS.
She has been institutionalized for most of her life. Her
parents were unrelated Saudi Arabs, and she had four
unaffected siblings, although the family history included
epilepsy and cerebral palsy in maternal cousins. Preg-
nancy was unremarkable, delivery was normal at term,
and she had no neonatal problems. This study was per-
formed in accordance with the regulations of the King
Saud University College of Medicine Ethics Committee
(approval # E-09-010), and the proband’s legal guardian
signed informed consent. The study adhered to the
tenets of the Declaration of Helsinki.
At the age of 10 months, she developed flexion myo-
clonic jerks with hypsarrhythmia on EEG typical of
infantile spasms, and she was treated with a course of
prednisone (2 mg/kg) and clonazepam. A repeat EEG
was moderately abnormal with multifocal epileptic dis-
charges consistent with secondary symptomatic epilepsy,
and she was started on the anticonvulsants vigabatrin
and clonazepam and on risperidone for autistic beha-
vior. Vigabatrin was successfully withdrawn and replaced
by lamotrigine with no seizures after the age of 3 ½
years. She had delayed motor and cognitive functions,
sitting at 13 months and walking at 2 years. She never
developed speech, and she was diagnosed as severely
mentally retarded with autistic features at age 6 years
with a Vineland social maturity scale score of 31. She
was unable to feed herself and was incontinent of both
stool and urine.
Laboratory investigation revealed normal hematologic
indices, liver function, and electrolytes. Tandem mass
spectrometry (TMS) for metabolic disorders was unre-
markable. MRI of the brain and brainstem auditory
evoked responses were both normal.
On examination, she had growth retardation with
reduced weight (28.3 kg; <2 SD below the mean), height
(137 cm; < 2 SD), and head circumference (49 cm; < 3
SD). She had subtle dysmorphic features consistent with
a partial 9p duplication syndrome with deep set eyes,
small upper lip, webbing of the neck (Figure 1B) and
clinodactyly (Figure 1C). X-rays of hands and wrists
revealed normal bone age with osteoporosis and con-
firmed clinodactyly of the fifth finger (Figure 1D). She
Figure 1 Family pedigree and dysmophic features observed. A) Family pedigree identifying the proband as II-3. Dysmorphic features found
in the proband included B) webbing of the neck and C) fifth finger clinodactyly. D) X-ray of hands and wrists showed evidence of osteoporosis
and clinodactyly.
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rocutaneous disorders, but the dorsum of the left hand
and the bridge of her nose were hyperpigmented
because of self injury.
On neurologic examination, she was awake and alert
but unable to follow commands or speak other than
some echolalia and repetitiven o n - s p e c i f i cs o u n d s .S h e
moved all four extremities with normal tone; reflexes
were brisk, but toes were down going. Ophthalmologic
exam and ocular motility were grossly normal, but she
did not make eye contact. She responded appropriately
to visual threat and loud sounds. She was generally
quiet and motionless, typically leaning to one side in an
awkward posture, making stereotyped movements of her
hands and trunk, and frequently hitting her nose with
her hand and grinding her teeth. Social interaction was
minimal with no smile, response to commands, or copy-
ing of examiner’s movements. Applying DSM4-R criteria
and PDD assessment scale/screening questionnaire, a
psychiatric assessment yielded the diagnoses of (Axis I)
pervasive developmental disorder (autistic type) and
(Axis II) severe mental retardation.
Conventional cytogenetic analysis on GTG-banded
chromosomes was performed according to the standard
technique on cultured lymphocytes from the father (I-1),
the mother (I-2), the proband (II-3), and her unaffected
brother (II-1) after obtaining informed consent. GTG-
banded chromosomes analysis was not carried out on
individuals II-2, II-4 and II-5 (see Pedigree Figure 1A).
Agilent human CGH microarrays (Agilent Technolo-
gies, Santa Clara, CA, USA) were employed on indivi-
duals I-1, I-2, II-1, II-2, II-3, II-4, and II-5 using chips
containing unique oligonucleotides for 244,000 probes
(244 K) with average probe spacing across the human
genome of 6.4 Kb. Labeling reactions were performed
with 1 μg genomic DNA with Agilent Genomic DNA
Labeling Kit PLUS (Agilent Technologies) according to
manufacturer’s protocol, and the microarray chip was
then scanned by the Agilent Microarray Scanner.
Data analysis was performed by Agilent Feature
Extraction 9.1 and CGH Analytics 3.4. In brief, log2
expression ratios were computed and normalized for
forward and reverse fluor (i.e. dye-swap) experiments
using the CGH Analytics 3.4 software. Putative chromo-
some copy number changes were defined by intervals of
three or more adjacent probes with log2 ratios sugges-
tive of a deletion or duplication when compared with
the log2 ratios of adjacent probes. The quality-weighted
interval score algorithm (ADM2) was used to compute
and assist in the identification of aberrations for a given
sample. Controls were 258 normal individuals of similar
ethnic background. Genetic databases employed
included Genbank (http://www.ncbi.nlm.nih.gov/gen-
bank/), GeneCards (http://www.genecards.org/), the
Autism Chromosome Rearrangement Database (http://
projects.tcag.ca/autism), OMIM (http://www.ncbi.nlm.
nih.gov/sites/entrez?db=omim) and literature search on
PubMed (http://www.ncbi.nlm.nih.gov/pubmed).
Conventional cytogenetic analysis on GTG-banded
chromosomes revealed a female karyotype in the pro-
band with a marker chromosome (Figure 2A) in 69% of
the analyzed metaphases after counting more than 150
metaphase spreads; thus, her karyotype was 47,XX,+mar
[69]/46,XX[31]. The marker chromosome was relatively
small and was found in the proband but not in her par-
ents or unaffected sibling (II-1), all of whom had a nor-
mal karyotype. No other chromosomal abnormalities
were detected in the patient, or her parents, or her
tested unaffected sibling (II-1).
Oligonucleotide whole genome array CGH analysis
showed that the isolated marker chromosome originated
from 9p. The duplicated area started from the region
surrounding the CBWD1 locus and included 9p24.3 to
9p13.1 (from 153131 bp to 39131894 bp on chromo-
some 9) with a size of 38.9 Mb (Figure 2B). This gain of
chromosome 9p was detected only in the proband. Her
parents, unaffected siblings (II-1, II-2, II-4 and II-5), and
258 ethnically matched controls all had normal array
CGH results (Figure 2C). No other chromosomal
abnormality was detected in any individual examined by
array CGH.
The NCBI Map Viewer revealed that the duplicated area
encompassed 381 genes (Additional file 1: Table S1).
Analysis of the duplicated area identified: i) an area
extending from 9p22.3 to 9p22.2 previously identified as
critical for the 9p duplication syndrome [11]; ii) a region
extending from 9p22.1 to 9p13.1 previously reported to be
duplicated in a girl with minimal physical findings and
normal IQ [11] and iii) a potential ASD locus extending
from 9p24.3 to 9p23 (Figure 3). This potential ASD locus
is contained within the larger area identified by Szatmari
and colleagues (9p24.3 to 9p13.2) in their study of 33
CNV gains in patients with autism [5].
The first patient with trisomy 9p was described by
Rethore et al. in 1970 [12], and more than 150 patients
with partial or complete 9p trisomy have been reported
since then [13]. In most patients, the 9p trisomic segment
was derived from a parent carrying a reciprocal balanced
translocation and was accompanied by a concurrent dele-
tion of another chromosome. Isolated de novo duplica-
tions of 9p without a concurrent deletion are infrequent,
with 15 patients reported to date [11,14-26]. Typical
characteristics include growth and mental retardation,
microbrachycephaly, deep and wide-set eyes with down-
slanting palpebral fissures, prominent nasal root with a
bulbous nasal tip, down-turned corners of the mouth,
low-set ears, short fingers and toes with hypoplastic nails,
and delayed bone age. Clinodactyly has also been
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Page 3 of 7Figure 2 GTG-banded Karyotype and array CGH results. A) GTG-banded karyotype showing the marker chromosome (circled). B) Array CGH
demonstrating a chromosome 9p duplicated region in the proband (duplicated area is boxed). C) Array CGH results in parents, healthy siblings,
and controls were normal. Array CGH for individual II-2 is shown.
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chromosome 12 [27]. Our patient had only partial 9p
duplication features despitee n c o m p a s s i n gt h ee n t i r e9 p
duplication critical region (D9S162-D9S267; 9p22.3 to
9p22.2) in the duplication, and this may be because of
the mosaic nature of the duplication.
One landmark study [28] provided evidence that chro-
mosomal mosaicism plays an important role in the gen-
eration of meiotic aneuploidy, which in turn is
recognized as a leading cause of human prenatal death,
congenital malformations, and learning disabilities [29].
The largest study to date on mosaicism in autistic boys
found mosaic aneuploidy in 19 of 116 children (16%)
with idiopathic autism [30]. The degree of mosaicism in
our patient (69%) may imply that gene dosage of 9p is a
factor contributing to autistic features; however, this
remains unproven because other tissues, including brain,
were not available.
We describe a 17-year-old Saudi girl with autism asso-
ciated with mental retardation and seizures despite a
non-focal neurologic examination and unremarkable
neuroimaging [31]. Autism has not been associated pre-
viously with an isolated 9p duplication [13], but this
patient had a large, isolated, mosaic 9p24.3 to 9p13.1
duplication that is likely symptomatic given that the
duplication was de novo,t h a ti tw a sn o tap o l y m o r p h i c
variant, that it segregated with autism in this family, and
that some genes in the duplicated region have been
linked previously to autistic features.
She had a potential ASD locus extending from 9p24.3
to 9p23 (Figure 3) which, after removing hypothetical
genes, encompassed 34 genes (Additional file 2: Table
S2) .T h er o l eo f1 6o ft h e s eg e n e si na u t i s mc o u l dn o t
be assessed because they have unknown function using
available databases and literature (see Methods). Of the
18 genes with known function, five (FOXD4L4,
FOXD44L2, FOXD4, FOXD4L1 and FOXD2, all in the
forkhead box gene family) are involved in transcription
regulation. The very low density lipoprotein receptor
gene (VLDLR) belongs to a well-known family of similar
genes that have the ability to transduce a diversity of
extracellular signals across neuronal membranes in the
adult central nervous system. Their role in modulating
synaptic plasticity and their necessity in hippocampus-
specific learning and memory are well documented [32].
Szatmari et al [5] and others [33-36] suggested that the
genes DOCK8, DMRT1, DMRT3,a n dDMRT2 from this
area of 9p may contribute to the autistic spectrum dis-
order phenotype [35]. The remaining eight genes in this
locus (KANK1, EIF1, LOC642350, BHLHB3, SMARCA2,
KCNV2, GPS2 and ATP5H) are involved in biological
processes such as regulation of actin polymerization,
nucleic acid binding, nucleotide and chromatin organi-
zation, mediating voltage-dependent potassium ion per-
meability, intracellular signaling, and ATP synthesis. No
conclusion could be reached at this time about whether
they may be involved in autism or ASD.
Conclusion
To our knowledge, this is the first report of an autistic
patient with an isolated mosaic de novo 9p duplication.
Analysis of the duplicated area identified a potential
ASD locus 9p24.3 to 9p23, implying that screening this
area for copy number variations by array CGH may help
identify specific gene(s) contributing to autism or ASD.
Additional material
Additional file 1: Supplementary Table S1. Genes encompassed in the
duplicated area.
Additional file 2: Supplementary Table S2. Potentially important
genes in the duplicated area.
Abbreviations
Array CGH: Array comparative genomic hybridization; ASD: Autism spectrum
disorders; CNVs: Copy number variations; DSM: Diagnostic and statistical
Figure 3 Ideogram showing the duplicated area. Chromosome 9
ideogram illustrating (to left, boxed) the overall duplicated area and
(to right, labeled) the duplicated area in a normal individual, the 9p
duplication syndrome critical region, and the potential ASD locus.
Abu-Amero et al. BMC Medical Genetics 2010, 11:135
http://www.biomedcentral.com/1471-2350/11/135
Page 5 of 7manual of mental disorders; EEG: Electroencephalogram; mar: marker; MRI:
Magnetic resonance imaging; PCR: Polymerase chain reaction; PDD:
Pervasive developmental disorders; SD: Standard deviation; TMS: Tandem
mass spectrometry
Acknowledgements
This work was supported by the Research Center of College of Medicine,
King Saud University, Riyadh, Saudi Arabia. KAA and TMB were supported in
part by the Glaucoma Research Chair of the Department of Ophthalmology,
College of Medicine, King Saud University. Written consent was obtained
from the patient or their relative for publication of this study.
Author details
1the Ophthalmic Genetics Laboratory, Department of Ophthalmology,
College of Medicine, King Saud University, Riyadh, Saudi Arabia.
2the PGD
Laboratory, Saad Specialist Hospital, Al-Khobar, Saudi Arabia.
3the
Department of Pediatrics (Division of Pediatric Neurology), College of
Medicine, King Saud University, Riyadh, Saudi Arabia.
4Department of
Pediatrics, Security Forces Hospital, Riyadh, Saudi Arabia.
5Psychiatry
Department, Security Forces Hospital, Riyadh, Saudi Arabia.
6Department of
Pathology (Cytogenetics Laboratory), King Khalid University Hospital, Riyadh,
Saudi Arabia.
7the Division of Neurology, Cooper University Hospital,
Camden, NJ, USA.
Authors’ contributions
KKA was in charge of study design, analysis of genetic data, and writing the
genetic part of the manuscript. AH carried out array CGH studies. MAS, MZS,
TSE and TMB were all essential in clinical evaluation of the patient and
compiling the clinical data in the manuscript. GZ carried out the
karyotyping. TMB was in charge of the overall project design, assessing
clinical and genetic data, and writing the manuscript. All authors read and
approved the final manuscript.
Competing interests
The authors declare that they have no competing interests.
Received: 22 April 2010 Accepted: 21 September 2010
Published: 21 September 2010
References
1. Newschaffer CJ, Croen LA, Daniels J, Giarelli E, Grether JK, Levy SE,
Mandell DS, Miller LA, Pinto-Martin J, Reaven J, et al: The epidemiology of
autism spectrum disorders. Annu Rev Public Health 2007, 28:235-258.
2. Al-Salehi SM, Al-Hifthy EH, Ghaziuddin M: Autism in Saudi Arabia:
presentation, clinical correlates and comorbidity. Transcult Psychiatry 2009,
46(2):340-347.
3. Vorstman JA, Staal WG, van Daalen E, van Engeland H, Hochstenbach PF,
Franke L: Identification of novel autism candidate regions through
analysis of reported cytogenetic abnormalities associated with autism.
Mol Psychiatry 2006, 11(1):18-28, 1.
4. Sebat J, Lakshmi B, Malhotra D, Troge J, Lese-Martin C, Walsh T, Yamrom B,
Yoon S, Krasnitz A, Kendall J, et al: Strong association of de novo copy
number mutations with autism. Science 2007, 316(5823):445-449.
5. Szatmari P, Paterson AD, Zwaigenbaum L, Roberts W, Brian J, Liu XQ,
Vincent JB, Skaug JL, Thompson AP, Senman L, et al: Mapping autism risk
loci using genetic linkage and chromosomal rearrangements. Nat Genet
2007, 39(3):319-328.
6. Marshall CR, Noor A, Vincent JB, Lionel AC, Feuk L, Skaug J, Shago M,
Moessner R, Pinto D, Ren Y, et al: Structural variation of chromosomes in
autism spectrum disorder. Am J Hum Genet 2008, 82(2):477-488.
7. Weiss LA, Shen Y, Korn JM, Arking DE, Miller DT, Fossdal R, Saemundsen E,
Stefansson H, Ferreira MA, Green T, et al: Association between
microdeletion and microduplication at 16p11.2 and autism. N Engl J Med
2008, 358(7):667-675.
8. Glessner JT, Wang K, Cai G, Korvatska O, Kim CE, Wood S, Zhang H, Estes A,
Brune CW, Bradfield JP, et al: Autism genome-wide copy number
variation reveals ubiquitin and neuronal genes. Nature 2009,
459(7246):569-573.
9. Klauck SM: Genetics of autism spectrum disorder. Eur J Hum Genet 2006,
14(6):714-720.
10. Craddock N, O’Donovan MC, Owen MJ: Psychosis genetics: modeling the
relationship between schizophrenia, bipolar disorder, and mixed (or
“schizoaffective”) psychoses. Schizophr Bull 2009, 35(3):482-490.
11. Bonaglia MC, Giorda R, Carrozzo R, Roncoroni ME, Grasso R, Borgatti R,
Zuffardi O: 20-Mb duplication of chromosome 9p in a girl with minimal
physical findings and normal IQ: narrowing of the 9p duplication critical
region to 6 Mb. Am J Med Genet 2002, 112(2):154-159.
12. Rethore MO, Larget-Piet L, Abonyi D, Boeswillwald M, Berger R,
Carpentier S, Cruveiller J, Dutrillau B, Lafourcade J, Penneau M, et al: [4
cases of trisomy for the short arm of chromosome 9. Individualization of
a new morbid entity]. Ann Genet 1970, 13(4):217-232.
13. Zou YS, Huang XL, Ito M, Newton S, Milunsky JM: Further delineation of
the critical region for the 9p-duplication syndrome. Am J Med Genet A
2009, 149A(2):272-276.
14. Chiyo H, Furuyama J, Suehara N, Obashi Y, Kikkawa H: Possible
intrachromosomal duplication in a case of trisomy 9p. Hum Genet 1976,
34(2):217-221.
15. Baccichetti C, Lenzini E, Forabosco A, Baroncini A, Dordo B, Mengarda G:
[The syndrome of trisomy 9p and presentation of 2 new cases].
Pathologica 1979, 71(1013):347-348.
16. Fryns JP, Casaer P, Van den Berghe H: Partial duplication of the short arm
of chromosome 9 (p13 leads to p22) in a child with typical 9p trisomy
phenotype. Hum Genet 1979, 46(2):231-235.
17. Zadeh TM, Funderburk SJ, Carrel R, Dumars KW: 9p duplication confirmed
by gene dosage effect: report of two patients. Ann Genet 1981,
24(4):242-244.
18. Cuoco C, Gimelli G, Pasquali F, Poloni L, Zuffardi O, Alicata P, Battaglino G,
Bernardi F, Cerone R, Cotellessa M, et al: Duplication of the short arm of
chromosome 9. Analysis of five cases. Hum Genet 1982, 61(1):3-7.
19. Coco R, Penchaszadeh VB: Cytogenetic findings in 200 children with
mental retardation and multiple congenital anomalies of unknown
cause. Am J Med Genet 1982, 12(2):155-173.
20. Motegi T, Watanabe K, Nakamura N, Hasegawa T, Yanagawa Y: De novo
tandem duplication 9p (p12——p24) with normal GALT activity in red
cells. J Med Genet 1985, 22(1):64-66.
21. Mattina T, Sorge G, Milone G, Garozzo R, Conti L: Duplication 9p due to
unequal sister chromatid exchange. J Med Genet 1987, 24(5):303-305.
22. Fujimoto A, Lin MS, Schwartz S: Direct duplication of 9p22–>p24 in a
child with duplication 9p syndrome. Am J Med Genet 1998, 77(4):268-271.
23. Stumm M, Musebeck J, Tonnies H, Volleth M, Lemke J, Chudoba I,
Wieacker P: Partial trisomy 9p12p21.3 with a normal phenotype. JM e d
Genet 2002, 39(2):141-144.
24. Krepischi-Santos AC, Vianna-Morgante AM: Disclosing the mechanisms of
origin of de novo short-arm duplications of chromosome 9. Am J Med
Genet A 2003, 117A(1):41-46.
25. Temtamy SA, Kamel AK, Ismail S, Helmy NA, Aglan MS, El Gammal M, El
Ruby M, Mohamed AM: Phenotypic and cytogenetic spectrum of 9p
trisomy. Genet Couns 2007, 18(1):29-48.
26. Roohi J, Tegay DH, Pomeroy JC, Burkett S, Stone G, Stanyon R, Hatchwell E:
A de novo apparently balanced translocation [46,XY,t(2;9)(p13;p24)]
interrupting RAB11FIP5 identifies a potential candidate gene for autism
spectrum disorder. Am J Med Genet B Neuropsychiatr Genet 2008,
147B(4):411-417.
27. de Pater JM, Ippel PF, van Dam WM, Loneus WH, Engelen JJ:
Characterization of partial trisomy 9p due to insertional translocation by
chromosomal (micro)FISH. Clin Genet 2002, 62(6):482-487.
28. Hulten MA, Patel SD, Tankimanova M, Westgren M, Papadogiannakis N,
Jonsson AM, Iwarsson E: On the origin of trisomy 21 Down syndrome.
Mol Cytogenet 2008, 1:21.
29. Iourov IY, Vorsanova SG, Yurov YB: Chromosomal mosaicism goes global.
Mol Cytogenet 2008, 1:26.
30. Yurov YB, Vorsanova SG, Iourov IY, Demidova IA, Beresheva AK, Kravetz VS,
Monakhov VV, Kolotii AD, Voinova-Ulas VY, Gorbachevskaya NL:
Unexplained autism is frequently associated with low-level mosaic
aneuploidy. J Med Genet 2007, 44(8):521-525.
31. Youroukos S: Autism and Epilepsy. ENCEPHALOS Archives of Neurology and
Phychiatry 2007, 44(2):200-203.
32. Qiu S, Korwek KM, Weeber EJ: A fresh look at an ancient receptor family:
emerging roles for low density lipoprotein receptors in synaptic
plasticity and memory formation. Neurobiol Learn Mem 2006, 85(1):16-29.
Abu-Amero et al. BMC Medical Genetics 2010, 11:135
http://www.biomedcentral.com/1471-2350/11/135
Page 6 of 733. Ottolenghi C, Veitia R, Barbieri M, Fellous M, McElreavey K: The human
doublesex-related gene, DMRT2, is homologous to a gene involved in
somitogenesis and encodes a potential bicistronic transcript. Genomics
2000, 64(2):179-186.
34. Ottolenghi C, Veitia R, Quintana-Murci L, Torchard D, Scapoli L, Souleyreau-
Therville N, Beckmann J, Fellous M, McElreavey K: The region on 9p
associated with 46,XY sex reversal contains several transcripts expressed
in the urogenital system and a novel doublesex-related domain.
Genomics 2000, 64(2):170-178.
35. Vinci G, Chantot-Bastaraud S, El Houate B, Lortat-Jacob S, Brauner R,
McElreavey K: Association of deletion 9p, 46,XY gonadal dysgenesis and
autistic spectrum disorder. Mol Hum Reprod 2007, 13(9):685-689.
36. Veitia RA, Nunes M, Quintana-Murci L, Rappaport R, Thibaud E, Jaubert F,
Fellous M, McElreavey K, Goncalves J, Silva M, et al: Swyer syndrome and
46,XY partial gonadal dysgenesis associated with 9p deletions in the
absence of monosomy-9p syndrome. Am J Hum Genet 1998,
63(3):901-905.
Pre-publication history
The pre-publication history for this paper can be accessed here:
http://www.biomedcentral.com/1471-2350/11/135/prepub
doi:10.1186/1471-2350-11-135
Cite this article as: Abu-Amero et al.: A de novo marker chromosome
derived from 9p in a patient with 9p partial duplication syndrome and
autism features: genotype-phenotype correlation. BMC Medical Genetics
2010 11:135.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Abu-Amero et al. BMC Medical Genetics 2010, 11:135
http://www.biomedcentral.com/1471-2350/11/135
Page 7 of 7